372 results on '"Alber, Hannes"'
Search Results
2. Same-day discharge after percutaneous coronary procedures—Structured review and comprehensive meta-analysis
3. Same-day discharge after percutaneous coronary procedures—Consensus statement of the working group of interventional cardiology (AGIK) of the Austrian Society of Cardiology
4. A randomized comparison of the treatment sequence of percutaneous coronary intervention and transcatheter aortic valve implantation: Rationale and design of the TAVI PCI trial
5. Empfehlung zum Einsatz kardialer Biomarker in der ESC-Leitlinie für perioperatives Management von Patient:innen bei nicht-kardiochirurgischen Operationen: Herausforderungen und Chancen
6. Risk prediction models for discrete ordinal outcomes: calibration and the impact of the proportional odds assumption
7. Simulation of bempedoic acid and ezetimibe in the lipid-lowering treatment pathway in Austria using the contemporary SANTORINI cohort of high and very high risk patients
8. Ertugliflozin to reduce arrhythmic burden in ICD/CRT patients (ERASe-trial) – A phase III study
9. Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial
10. Impact of EMpagliflozin on cardiac function and biomarkers of heart failure in patients with acute MYocardial infarction—The EMMY trial
11. An ordinal prediction model of the diagnosis of non-obstructive coronary artery and multi-vessel disease in the CARDIIGAN cohort
12. In-Hospital Outcome Comparing Bivalirudin to Heparin in Real-World Primary Percutaneous Coronary Intervention
13. Successful long-term management of spasticity in patients with multiple sclerosis using a software application (APP): A pilot study
14. Changes and innovations of the 2017 ESC guidelines on dual antiplatelet therapy in coronary artery disease—a review
15. Conservative versus Invasive Strategy in Elderly Patients with Non-ST-Elevation Myocardial Infarction: Insights from the International POPular Age Registry
16. Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction: The ATLANTIC-H24 Analysis
17. Improved outcomes of elderly patients treated with drug-eluting versus bare metal stents in large coronary arteries: Results from the BAsel Stent Kosten-Effektivitäts Trial PROspective Validation Examination randomized trial
18. Kardiologische Therapie bei Hochbetagten
19. Tradeoff between bleeding and stent thrombosis in different dual antiplatelet therapy regimes: Importance of case fatality rates and effective treatment durations
20. Sekundärpräventive Antiplättchentherapie in der kardiologischen Rehabilitation
21. Expert position paper on prolonged dual antiplatelet therapy in secondary prevention following myocardial infarction
22. A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction
23. Dutogliptin in Combination with Filgrastim in Early Recovery Post-Myocardial Infarction—The REC-DUT-002 Trial
24. Heart rate at discharge and long-term prognosis following percutaneous coronary intervention in stable and acute coronary syndromes — results from the BASKET PROVE trial
25. Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease
26. Comparison of Brachial Artery Wall Thickness Versus Endothelial Function to Predict Late Cardiovascular Events in Patients Undergoing Elective Coronary Angiography
27. Empagliflozin in acute myocardial infarction: the EMMY trial
28. Impact of cirrhotic cardiomyopathy and severity of liver cirrhosis on the development of acute kidney injury
29. Infuence of cirrhotic cardiomyopathy defined according to the new multidisciplinary diagnostic criteria on overall mortality among cirrhotic patients
30. Risk prediction models for discrete ordinal outcomes: Calibration and the impact of the proportional odds assumption
31. Comparison of Peripheral Endothelial Function in Shift Versus Nonshift Workers
32. Impact of stent diameter and length on in‐stent restenosis after DES vs BMS implantation in patients needing large coronary stents—A clinical and health‐economic evaluation
33. Sex differences in independent factors associated with coronary artery disease
34. Risk prediction models for discrete ordinal outcomes: Calibration and the impact of the proportional odds assumption
35. Neopterin, CD4+CD28− lymphocytes and the extent and severity of coronary artery disease
36. Prasugrel vs. Ticagrelor in acute coronary syndromes: Which one to choose?
37. Akutes Koronarsyndrom: Einfluss der PCI per se auf das antithrombotische Regime und Ergebnis
38. Prognosis and Risk Factors in Patients With Asymptomatic Aortic Stenosis and Their Modulation by Atorvastatin (20 mg)
39. Ein „gefährliches Duo“: Diabetes-spezifische Aspekte der Koronaren Herzkrankheit
40. Primary percutaneous intervention of ST-elevation myocardial infarction in Austria: Results from the Austrian acute PCI registry 2005–2007
41. STEMI-Guidelines 2008 – Konsequenzen für die heutige Infarktversorgung im ländlichen Raum?
42. Gesundheitsbezogene Lebensqualität, Angst und Depression vor und nach einer aortokoronaren Bypass-Operation
43. Drug-eluting versus bare-metal stents in large coronary arteries
44. Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial
45. Empagliflozin in acute myocardial infarction: the EMMY trial.
46. Effect of atorvastatin on peripheral endothelial function and systemic inflammatory markers in patients with stable coronary artery disease
47. The role of inflammation in the pathophysiology of acute coronary syndromes
48. Successful switch from inhalative iloprost to oral bosentan in portopulmonary hypertension associated with liver cirrhosis
49. Effect of atorvastatin on circulating proinflammatory T-lymphocyte subsets and soluble CD40 ligand in patients with stable coronary artery disease—A randomize, placebo-controlled study
50. Is RAMIT reflecting the real world?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.